IMNM has also been divided into 3 clinico-immunological phenotypes: anti-Signal Recognition Particle (anti-SRP) myopathy, anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) myopathy and seronegative IMNM. This evidence concerns the gene UCN2 and myopathy.